Cetiedil: its potential usefulness in sickle cell disease.
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D001665:Binding Sites; D002470:Cell Survival / Q000187:drug effects; D003485:Cyanates / Q000494:pharmacology; D004285:Dogs; D004338:Drug Combinations; D004910:Erythrocyte Membrane / Q000187:drug effects; D004913:Erythrocytes, Abnormal / Q000187:drug effects; D005374:Filtration; D005914:Globins; D006454:Hemoglobins; D006801:Humans; D013876:Thiophenes / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D000700:Analgesics; D001381:Azepines; D003485:Cyanates; D004338:Drug Combinations; D006454:Hemoglobins; D013876:Thiophenes; D014665:Vasodilator Agents; C006955:cetiedil; D005914:Globins